Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Jenburkt Pharmaceuticals Ltd
BSE:524731
Jenburkt Pharmaceuticals Ltd
BSE:524731
Price:
925.4
INR
0.84%
Market Closed
Market Cap:
₹4.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Jenburkt Pharmaceuticals Ltd
BSE:524731
|
IN |
|
RFA Financial Inc
OTC:RFAFF
|
CA |
|
C
|
CapitaLand Integrated Commercial Trust
XMUN:M3T
|
SG |
|
H
|
Hamayuu Co Ltd
TSE:7682
|
JP |
|
Upbound Group Inc
NASDAQ:UPBD
|
US |
Wall St Price Targets
JENBURPH Price Forecast
Based on 3 analysts
Based on 3 analysts
+51% Upside
from
₹925.4
today
Jenburkt Pharmaceuticals Ltd (524731)’s 12-month stock price forecast through October 2027 has a consensus target of ₹1 397.4, implying 51% upside. The forecast is based on price targets from 3 Wall Street analysts.
JENBURPH Analyst Rating
No ratings yet
No ratings yet
Jenburkt Pharmaceuticals Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is JENBURPH's stock price target?
Price Target
1 397.4
INR
1 397.4
INR
According to Wall Street analysts, the average 1-year price target for JENBURPH is 1 397.4 INR with a low forecast of 1 383.7 INR and a high forecast of 1 438.5 INR.
What is the Revenue forecast for Jenburkt Pharmaceuticals Ltd?
Projected CAGR
-65%
-65%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 2 years is -65%.
What is the Gross Profit forecast for Jenburkt Pharmaceuticals Ltd?
Projected CAGR
20%
20%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next -10 years is 20%.
What is the Operating Income forecast for Jenburkt Pharmaceuticals Ltd?
Projected CAGR
-64%
-64%
Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 2 years is -64%.
What is the Pre-Tax Income forecast for Jenburkt Pharmaceuticals Ltd?
Projected CAGR
-64%
-64%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 2 years is -64%.
What is the Net Income forecast for Jenburkt Pharmaceuticals Ltd?
Projected CAGR
-64%
-64%
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 2 years is -64%.